Power Law company profile

LumiraDx

Health Tech & Medtech · London, United Kingdom · Founded 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$382M

Market cap · 2026

Revenue

$254M

Latest reported FY

Global footprint

Where LumiraDx has talent and traffic

Web traffic by country

130 monthly visits
across markets

🇺🇸 United States76.9%

Top 1 markets shown

Patent intelligence

$44M patent portfolio · 36 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$44M

11.4% of market cap · 6× smaller than top peer CMR Surgical ($263M)

36 active patent families

Where LumiraDx innovates ChemistryNucleic acidPhysicsReference sampleBiomedical engineering

Tech-focus vs peers

Where LumiraDx concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across LumiraDx and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See LumiraDx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo